AMAG Pharmaceuticals Overview

AMAG Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for AMAG.

Quarterly Cost of Revenue

$13.34M

↓ 36.79% YoY

As of Sep 30, 2020

Annual Cost of Revenue (TTM)

$99.20M

↑ 13.87% YoY

Trailing 12 months ending Sep 30, 2020

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin